CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.61−0.02 (-3.60%)
Close on Nov 13, 2026Market cap $16.18MP/E –Yield –
CVRx cash
Cash and short-term investments held at the end of each period.
CVRx's cash was $58.75M at Sep 30, 2026. For fiscal 2025 it was $75.71M, down 28.5% from the year before. The highest annual figure on record is $142.07M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.71M | -28.5% |
| FY2024 | Dec 31, 2024 | $105.93M | +17.0% |
| FY2023 | Dec 31, 2023 | $90.57M | -14.7% |
| FY2022 | Dec 31, 2022 | $106.19M | -25.3% |
| FY2021 | Dec 31, 2021 | $142.07M | +140.3% |
| FY2020 | Dec 31, 2020 | $59.11M | +129.6% |
| FY2019 | Dec 31, 2019 | $25.74M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $58.75M | -31.0% |
| Q2 FY2026 | Jun 30, 2026 | $64.59M | -32.0% |
| Q1 FY2026 | Mar 31, 2026 | $72.30M | -29.6% |
| Q4 FY2025 | Dec 31, 2025 | $75.71M | -28.5% |
| Q3 FY2025 | Sep 30, 2025 | $85.12M | -15.0% |
| Q2 FY2025 | Jun 30, 2025 | $95.03M | +35.0% |
| Q1 FY2025 | Mar 31, 2025 | $102.67M | +28.2% |
| Q4 FY2024 | Dec 31, 2024 | $105.93M | +17.0% |
| Q3 FY2024 | Sep 30, 2024 | $100.16M | +20.7% |
| Q2 FY2024 | Jun 30, 2024 | $70.40M | -22.5% |
| Q1 FY2024 | Mar 31, 2024 | $80.12M | -22.4% |
| Q4 FY2023 | Dec 31, 2023 | $90.57M | -14.7% |
| Q3 FY2023 | Sep 30, 2023 | $82.99M | -24.5% |
| Q2 FY2023 | Jun 30, 2023 | $90.82M | -25.2% |
| Q1 FY2023 | Mar 31, 2023 | $103.28M | -21.3% |
| Q4 FY2022 | Dec 31, 2022 | $106.19M | -25.3% |
| Q3 FY2022 | Sep 30, 2022 | $109.99M | -35.6% |
| Q2 FY2022 | Jun 30, 2022 | $121.35M | +157.5% |
| Q1 FY2022 | Mar 31, 2022 | $131.18M | +143.1% |
| Q4 FY2021 | Dec 31, 2021 | $142.07M | +140.3% |
| Q3 FY2021 | Sep 30, 2021 | $170.91M | +170.0% |
| Q2 FY2021 | Jun 30, 2021 | $47.13M | +151.0% |
| Q1 FY2021 | Mar 31, 2021 | $53.97M | +109.7% |
| Q4 FY2020 | Dec 31, 2020 | $59.11M | – |
| Q3 FY2020 | Sep 30, 2020 | $63.30M | – |
| Q2 FY2020 | Jun 30, 2020 | $18.77M | – |
| Q4 FY2019 | Dec 31, 2019 | $25.74M | – |
See a number that looks wrong?